These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24497563)

  • 1. Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up.
    Derchi G; Balocco M; Bina P; Caruso V; D'Ascola DG; Littera R; Origa R; Cappellini MD; Forni GL
    Haematologica; 2014 Feb; 99(2):e17-8. PubMed ID: 24497563
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to "efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up " Haematologica 2014;99(2):e17-18.
    Klings ES; Vichinsky EP; Morris CR
    Haematologica; 2014 Feb; 99(2):e19. PubMed ID: 24497564
    [No Abstract]   [Full Text] [Related]  

  • 3. Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension.
    Morris CR; Kim HY; Wood J; Porter JB; Klings ES; Trachtenberg FL; Sweeters N; Olivieri NF; Kwiatkowski JL; Virzi L; Singer ST; Taher A; Neufeld EJ; Thompson AA; Sachdev V; Larkin S; Suh JH; Kuypers FA; Vichinsky EP;
    Haematologica; 2013 Sep; 98(9):1359-67. PubMed ID: 23585527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
    Gordeuk VR
    Haematologica; 2005 Apr; 90(4):433-4. PubMed ID: 15820926
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
    Derchi G; Forni GL; Formisano F; Cappellini MD; Galanello R; D'Ascola G; Bina P; Magnano C; Lamagna M
    Haematologica; 2005 Apr; 90(4):452-8. PubMed ID: 15820939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical application of sildenafil in porto pulmonary hypertension].
    Shen YC; Wen FQ; Yi Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Sep; 34(9):691-3. PubMed ID: 22177497
    [No Abstract]   [Full Text] [Related]  

  • 7. Sildenafil for pulmonary arterial hypertension complicating respiratory disease.
    Aggarwal AN
    Indian J Chest Dis Allied Sci; 2008; 50(4):317-9. PubMed ID: 19035049
    [No Abstract]   [Full Text] [Related]  

  • 8. Sildenafil in idiopathic pulmonary fibrosis.
    Maher TM
    N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sildenafil treatment of unilateral pulmonary edema and pulmonary hypertension in pulmonary artery agenesis].
    Rodríguez-Gómez F; Martín I; Sánchez A; Pujol E
    Rev Esp Cardiol; 2006 Dec; 59(12):1347-9. PubMed ID: 17194435
    [No Abstract]   [Full Text] [Related]  

  • 10. Sildenafil in older patients with secondary pulmonary hypertension.
    Minotti GC; Corsonello A; Incalzi RA
    J Am Geriatr Soc; 2007 Oct; 55(10):1681-2. PubMed ID: 17908072
    [No Abstract]   [Full Text] [Related]  

  • 11. Sildenafil for pulmonary hypertension in ARDS: a new pleasant effect?
    Blanch L; Albaiceta GM
    Intensive Care Med; 2010 May; 36(5):729-31. PubMed ID: 20130829
    [No Abstract]   [Full Text] [Related]  

  • 12. Sildenafil: a definitive NO in COPD.
    Vonk-Noordegraaf A; Boerrigter BG
    Eur Respir J; 2013 Oct; 42(4):893-4. PubMed ID: 24081756
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiating the pulmonary vasodilatory effects produced by sildenafil.
    Dias-Junior CA
    Respir Med; 2007 May; 101(5):1041; author reply 1042. PubMed ID: 17321734
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic approaches to pulmonary hypertension in hemoglobinopathies: Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy.
    Derchi G; Forni GL
    Ann N Y Acad Sci; 2005; 1054():471-5. PubMed ID: 16339700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension.
    Dumitrescu D; Seck C; Möhle L; Erdmann E; Rosenkranz S
    Int J Cardiol; 2012 Jan; 154(2):205-6. PubMed ID: 22104986
    [No Abstract]   [Full Text] [Related]  

  • 16. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
    Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update in the management of persistent pulmonary hypertension of the newborn].
    Viellevoye R; Rigo V; Rigo J
    Rev Med Liege; 2007; 62(5-6):284-7. PubMed ID: 17725195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension occurrence after liver transplant in systemic sclerosis: a report of 2 cases sustainably treated by sildenafil.
    Koumakis E; Wipff J; Kahan A; Allanore Y
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S53-4. PubMed ID: 20576215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.
    Moreno HJ
    J Vet Intern Med; 2007; 21(6):1165. PubMed ID: 18196719
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of sildenafil in the evaluation of candidates for heart transplantation.
    Maffini Eda R; Demore LS; Wilhelms RC
    Arq Bras Cardiol; 2013 Feb; 100(2):198. PubMed ID: 23503831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.